Evidence map›Paper›PMID 30778127›Full record

ReviewBone marrow transplantation2019

"Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries".

Mahmoud Aljurf, Daniel Weisdorf, Feras Alfraih, Jeff Szer, Carlheinz Müller, Dennis Confer, Shahrukh Hashmi, Nicolaus Kröger, Bronwen E Shaw, Hildegard Greinix and 17 more

Abstract readReview
In one paragraph

Review in Bone marrow transplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Stem cell therapies in the clinic.Bioengineering & translational medicine · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. 'International journal of environmental research and public health · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Increasing access to allogeneic hematopoietic cell transplant: an international perspective.Hematology. American Society of Hematology. Education Program · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Mahmoud AljurfAdult Hematology/HSCT, Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Daniel WeisdorfUniversity of Minnesota, Minneapolis, MN, USA.
Feras AlfraihAdult Hematology/HSCT, Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia. falfraih@kfshrc.edu.sa.
Jeff SzerClinical Haematology at Peter MacCallum Cancer Centre and Royal Melbourne Hospital, VIC, 3050, Australia.ORCID 0000-0001-6783-2301
Carlheinz MüllerZentrales Knochenmarkspender-Register ZKRD, Ulm, BW, Germany.
Dennis ConferCenter for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, USA.
Shahrukh HashmiAdult Hematology/HSCT, Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Nicolaus KrögerUniversity Hospital Hamburg, Hamburg, Germany.
Bronwen E ShawCenter for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USA.
Hildegard GreinixMedical University of Graz, Division of Hematology, Graz, Austria.
Mohamed A Kharfan-DabajaMayo Clinic, Jacksonville, FL, USA.
Lydia FoekenWorld Marrow Donor Association, Leiden, Netherlands.
Adriana SeberHospital Samaritano de São Paulo, Sao Paulo, Brazil.
Syed AhmedAdult Hematology/HSCT, Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Areej El-JawahriMassachusetts General Hospital, Boston, MA, USA.
Moheeb Al-AwwamiAdult Hematology/HSCT, Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Aichi, Japan.
Marcelo PasquiniCenter for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USA.
Amr HanbaliAdult Hematology/HSCT, Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Hazzaa AlzahraniAdult Hematology/HSCT, Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Shinichiro OkamotoAsia-Pacific Blood and Marrow Transplantation Group (APBMT), Tokyo, Japan.
Eliane GluckmanEurocord Hôpital Saint-Louis and University Paris Diderot, Paris, France.
Mohamad MohtyHopital Saint-Antoine, Sorbonne University, INSERM UMRs 839, Paris, France.
Yoshihisa KoderaJapan Marrow Donor Program (JMDP), Tokyo, Japan.
Mary HorowitzCenter for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USA.
Dietger NiederwieserDepartment of Hematology and Medical Oncology, University Hospital, Leipzig, Germany.ORCID 0000-0002-4737-1103
Riad El FakihAdult Hematology/HSCT, Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia. riadfakih@hotmail.com.ORCID 0000-0003-4498-3865

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hematopoietic cell transplantation (HCT) activity is increasing at an unprecedented pace with > 50,000 allogeneic transplants occurring annually worldwide. Establishing a functional HCT donor registry can be very challenging with respect to ethnicities, financial, technical, and geopolitical issues. Extensive planning steps are essential to overcome the expected challenges while establishing the registry, and to maintain its functionality. A few strategies can help move past those challenges and push the development of such registries forward. Authorities involved in HCT donor registry establishment will have to balance the advantages and costs of such a project and accommodate the emerging alternatives such as cord blood or related haploidentical transplants. Miscalculations and incomplete understanding of the various aspects of the process can have tremendous impact on the optimization of a HCT donor registry especially in developing countries. Herein we present some challenges in establishing such a registry and present potential solutions.

Indexed as

Bone Marrow TransplantationHumansRegistriesTissue Donors

Identifiers

PMID30778127
PMCPMC6760540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.